Human Papilloma Virus (HPV)

The American College Health Association (ACHA) includes the Quadrivalent Human Papillomavirus (HPV) vaccine on its list of recommended immunizations for all female college students aged 11 to 26. See Recommendations for Institutional Prematriculation Immunizations (March 2013). According to the Centers for Disease Control, there are approximately 40 types of genital HBV, some of which can cause cervical cancer in women and other types of cancer in both men and women. A highly-effective HPV vaccination protects a woman from the four most virulent strains of HPV and reduces the potential for cervical cancer later in life. A three-dose regimen (given at 0, 2, and 6 months) is recommended for females aged 13-26 years if they did not receive it earlier. For additional details, see the CDC's HPV Vaccine: What You Need to Know.